topic

Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome
Mizuki Nishino, Anita Giobbie-Hurder, Nikhil H Ramaiya, F Stephen Hodi

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 40; DOI: 10.1186/s40425-014-0040-2
Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
David A Schaer, Daniel Hirschhorn-Cymerman, Jedd D Wolchok

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 7; DOI: 10.1186/2051-1426-2-7
Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells
Rachel E Beard, Zhili Zheng, Kiran H Lagisetty, William R Burns, Eric Tran, Stephen M Hewitt, Daniel Abate-Daga, Shannon F Rosati, Howard A Fine, Soldano Ferrone, Steven A Rosenberg, Richard A Morgan

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 25; DOI: 10.1186/2051-1426-2-25
Retinal vasculitis and ocular vitreous metastasis following complete response to PD-1 inhibition in a patient with metastatic cutaneous melanoma
Joshua S Manusow, Leila Khoja, Nataly Pesin, Anthony M Joshua, Efrem D Mandelcorn

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 41; DOI: 10.1186/s40425-014-0041-1
Cytokine responsiveness of CD8⁺ T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients
Richard G Everson, Richard M Jin, Xiaoyan Wang, Michael Safaee, Rudi Scharnweber, Dominique N Lisiero, Horacio Soto, Linda M Liau, Robert M Prins

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 10; DOI: 10.1186/2051-1426-2-10
Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program
Roxanne Payne, Lyn Glenn, Helena Hoen, Beverley Richards, John W Smith, Robert Lufkin, Todd S Crocenzi, Walter J Urba, Brendan D Curti

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 13; DOI: 10.1186/2051-1426-2-13
MAGE-specific T cells detected directly ex-vivo correlate with complete remission in metastatic breast cancer patients after sequential immune-endocrine therapy
Maxwell Janosky, Rachel L Sabado, Crystal Cruz, Isabelita Vengco, Farah Hasan, Arthur Winer, Linda Moy, Sylvia Adams

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 32; DOI: 10.1186/s40425-014-0032-2
Implementation of an Interleukin-2 National Registry: an opportunity to improve cancer outcomes
Michael K Wong, Howard L Kaufman, Gregory A Daniels, David F McDermott, Sandra Aung, James N Lowder, Michael A Morse

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 20; DOI: 10.1186/2051-1426-2-20
Opportunistic infections in patients treated with immunotherapy for cancer
Chrisann Kyi, Matthew D Hellmann, Jedd D Wolchok, Paul B Chapman, Michael A Postow

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 19; DOI: 10.1186/2051-1426-2-19
Ipilimumab in patients with melanoma and autoimmune disease
Chrisann Kyi, Richard D Carvajal, Jedd D Wolchok, Michael A Postow

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 35; DOI: 10.1186/s40425-014-0035-z

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages